Breaking News
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
January 18, 2018 - FDA Approves New Indication for Gilotrif (afatinib) in EGFR Mutation-Positive NSCLC
January 18, 2018 - Oncologists Dish on Top Issues for 2018
January 18, 2018 - Researchers identify new potential drug target for Huntington’s disease
January 18, 2018 - Metrohm USA welcomes employees to new headquarters in Florida
January 18, 2018 - Human waste remains main source of fecal pollution in the river Danube
January 18, 2018 - Expert discusses how to stay healthy during flu season
January 18, 2018 - New biomaterials-based system improves T-cell production
Risk of Oral Clefts with Topiramate May Be Dose-Dependent

Risk of Oral Clefts with Topiramate May Be Dose-Dependent

image_pdfDownload PDFimage_print

Action Points

  • The risk of oral clefts (cleft lip or palate) at birth was almost threefold higher among infants born to women exposed to topiramate compared with an unexposed group, with greater risk among women taking higher higher doses of the drug, in a study of women enrolled in Medicaid.
  • Note that unplanned pregnancies are common, occurring at a rate of about 50%, and topiramate is not recommended for pregnant women.

Higher doses of the anti-seizure drug topiramate taken during the first trimester of pregnancy were associated with a significantly increased risk for cleft lip or palate in the newborn, researchers found.

In an analysis of nearly 1.4 million women enrolled in Medicaid from 2000 to 2010, the risk of oral clefts at birth was almost threefold higher among infants born to women exposed to topiramate compared with an unexposed group (RR 2.90, 95% CI 1.56 to 5.40), Sonia Hernandez-Diaz, MD, of the Harvard T.H. Chan School of Public Health in Boston, and colleagues reported online in Neurology.

That risk was greater among women taking higher higher doses of the drug, they reported.

“While topiramate is not recommended for pregnant women, unplanned pregnancies are common [occurring at a rate of about 50%], so it’s important to fully examine any possible risk,” Hernandez-Diaz told MedPage Today. “Our study found that when a pregnant women took topiramate during the first trimester, baby’s risk of cleft lip or palate was three times greater than if mom was not taking the drug. The risk was higher when the mother took high doses of the drug than when she took lower doses.”

For their study, Hernandez-Diaz and colleagues looked at data from the 2000-2010 Medicaid Analytic eXtract on 1,360,101 pregnant women with a live-born infant enrolled in Medicaid from three months before conception through one month after delivery. A total of 2,425 infants were born to women exposed to topiramate during that time, and about 2,800 women had filled prescriptions for another anti-seizure drug, lamotrigine, which has been shown to be safer during pregnancy. Previous research has linked maternal use of topiramate early in pregnancy with a two- to five-fold increased risk of oral clefts in the infant, and also with low birth weight.

The researchers found that the risk of oral clefts at birth was 4.1 per 1,000 in the infants exposed to topiramate compared with 1.1 per 1,000 in those unexposed.

When looking at women taking topiramate specifically for epilepsy — indicating higher doses of the drug — the risk was even higher (RR 8.30, 95% CI 2.65 to 26.07). But among women taking the drug for bipolar — suggesting lower doses — the risk was not significant (RR 1.45, 95% CI 0.54 to 3.86). The median daily dose for the first prescription filled during the first trimester was 200 mg for women with epilepsy and 100 mg for women without epilepsy.

Indeed, they found that for topiramate monotherapy, risk of oral clefts was higher with higher doses: RR 5.16, 95% CI 1.94 to 13.73 for doses above 100 mg compared with a non-significant RR 1.64, 95% CI 0.53 to 5.07 for doses of 100 mg and below.

The researchers noted that results were similar when lamotrigine was used as the comparator.

“Questions remain as to whether the lower doses used for non-epilepsy indications also confer risk,” they wrote, adding that there’s particular concern for the weight-loss drug Qsymia, a combination of phentermine and topiramate, albeit at lower doses. “More low-dose exposures may result from future (unplanned) pregnancies,” they wrote.

Gregory Krauss, MD, of Johns Hopkins in Baltimore, who was not involved in the study, noted that while a number of studies have shown an increased risk of oral clefts with topiramate, “this study shows that it is dose-dependent.”

“When used for epilepsy at doses of 100 to 600 mg, there is substantial increased risk, whereas when used for headache and mood disorders at lower doses of 50 to 100 mg – as it has been in literally millions of people – the risk is minimal, and given the confidence intervals, didn’t really reach significance,” Krauss said.

The study was limited by the potential for selection bias and misclassification, but Hernandez-Dias said the results “suggest that women with epilepsy on topiramate have the highest relative risk of giving birth to a baby with cleft lip or cleft palate, likely due to the higher doses of topiramate when used for controlling seizures.”

“The best course may be to avoid prescribing high doses of topiramate to women of childbearing age unless the benefits clearly outweigh the risks,” she said.

This work was supported by the National Institute of Mental Health.

Hernandez-Diaz and several co-authors reported financial relationships with industry.


Tagged with:

About author

Related Articles